Wouter Van Loocke

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.

Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia.

Journal: HemaSphere

Published: August 14, 2023

Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma.

Human iPSC modeling recapitulates in vivo sympathoadrenal development and reveals an aberrant developmental subpopulation in familial neuroblastoma.

Journal: iScience

Published: December 20, 2022

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.

Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.

Journal: Cancers

Published: November 30, 2022

IRF2 is required for development and functional maturation of human NK cells.

IRF2 is required for development and functional maturation of human NK cells.

Journal: Frontiers in immunology

Published: September 07, 2022

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality.

TXNIP Promotes Human NK Cell Development but Is Dispensable for NK Cell Functionality.

Journal: International journal of molecular sciences

Published: August 04, 2022

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Journal: Science advances

Published: July 20, 2022

The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

The transcription factor RUNX2 drives the generation of human NK cells and promotes tissue residency.

Journal: eLife

Published: May 17, 2022

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation.

MEIS2 Is an Adrenergic Core Regulatory Transcription Factor Involved in Early Initiation of TH-MYCN-Driven Neuroblastoma Formation.

Journal: Cancers

Published: September 02, 2021

T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.

T-BET and EOMES Accelerate and Enhance Functional Differentiation of Human Natural Killer Cells.

Journal: Frontiers in immunology

Published: June 29, 2021

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.

ETV6-NCOA2 fusion induces T/myeloid mixed-phenotype leukemia through transformation of nonthymic hematopoietic progenitor cells.

Journal: Blood

Published: December 13, 2020

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.

Aging of preleukemic thymocytes drives CpG island hypermethylation in T-cell acute lymphoblastic leukemia.

Journal: Blood cancer discovery

Published: November 12, 2020

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice.

Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in mice.

Journal: The Journal of experimental medicine

Published: October 24, 2020

Showing 1-12 of 36

Last Updated: 09/26/2026